World Class Healthcare Technology Providers Presenting BIO-key Fingerprint Authentication at HIMSS 2014
February 20 2014 - 8:00AM
Marketwired
World Class Healthcare Technology Providers Presenting BIO-key
Fingerprint Authentication at HIMSS 2014
Compliance Requirements Driving Utilization of Biometric
Authentication for ePrescriptions
WALL, NJ--(Marketwired - Feb 20, 2014) - BIO-key
International, Inc. (OTCQB: BKYI), a global leader in fingerprint
biometric identification solutions, advanced mobile authentication
and identity assurance technologies, today announced that the
Company's healthcare integration partners including Allscripts
(#3944), Caradigm (#1047), Epic (2139), HealthCast Solutions
(#7045) and Key Source International (#1122) will be presenting our
fingerprint authentication solutions for EHR and patient
identification at HIMSS 2014, February 23rd - 27th, Orlando
Convention Center, Orlando, Florida.
Visit BIO-key at the HealthCast Solutions booth to see a
demonstration of fingerprint solutions for two-factor
authentication and EPCS. A representative from Rady's
Children's Hospital will be discussing the hospitals initial
impression of HealthCast Solutions Single Sign-On and BIO-key's
biometric fingerprint authentication.
On Wednesday, February 26th visit the Allscripts booth between
9:30am and 1:00pm to witness live demonstrations and sample
enrollments into Allscripts TouchWorks, Sunrise Clinical Manager
and Professional EHR. Learn how your organization can replace
cumbersome passwords with a secure and compliant biometric
solution.
"Our products enhance productivity and efficiency. Leading
hospitals utilize BIO-key to reduce the organizations' reliance on
passwords, meet compliance requirements for two-factor
authentication and EPCS while generating more time to care for
patients and enhancing the overall security of patient records,"
said Jay Meier, Vice President, Corporate Development at BIO-key.
"Organizations benefit from our unique ability to reduce the cost
of hardware associated with existing authentication platforms and
replace them with flexible, scalable and interoperable
software. Interoperability protects the investment and
prepares the hospital's IT department for the future of biometric
authentication on mobile devices."
About BIO-key BIO-key International, Inc., headquartered in
Wall, New Jersey, develops and delivers advanced identification
solutions to commercial and government enterprises, integrators,
and custom application developers. BIO-key's award winning, high
performance, scalable, cost-effective and easy-to-deploy biometric
finger identification technology accurately identifies and
authenticates users of wireless and enterprise applications. Our
solutions are used in local embedded OEM products as well as some
of the world's largest identification deployments to improve
security, guarantee identity, and help reduce identity
theft. BIO-key's technology is offered directly or by market
leading partners around the world. (http://www.bio-key.com)
BIO-key Safe Harbor Statement Certain statements contained in
this press release may be construed as "forward-looking statements"
as defined in the Private Securities Litigation Reform Act of 1995
(the "Act"). The words "estimate," "project," "intends,"
"expects," "anticipates," "believes" and similar expressions are
intended to identify forward-looking statements. Such
forward-looking statements are made based on management's beliefs,
as well as assumptions made by, and information currently available
to, management pursuant to the "safe-harbor" provisions of the
Act. These statements are subject to certain risks and
uncertainties that may cause actual results to differ materially
from those projected on the basis of these statements. These
risks and uncertainties include, without limitation, our history of
losses and limited revenue, our ability to develop new products and
evolve existing ones, wider market acceptance of biometric
technologies, our ability to raise additional financing, our
ability to attract and retain key personnel. For a more
complete description of these and other risk factors that may
affect the future performance of BIO-key International, Inc., see
"Risk Factors" in the Company's Annual Report on Form 10-K for the
year ended December 31, 2012 and its other filings with the
Securities and Exchange Commission. Readers are cautioned not
to place undue reliance on these forward-looking statements, which
speak only as of the date made. The Company undertakes no
obligation to disclose any revision to these forward-looking
statements whether to reflect events or circumstances after the
date hereof or otherwise.
Contact: BIO-key
International, Inc. Jay Meier VP Corp. Dev.
Jay.meier@bio-key.com 651-789-6116
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Aug 2024 to Sep 2024
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Sep 2023 to Sep 2024